Sr Manager, IT Business Analysis at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Act as technical lead for US Value & Access team, reporting to Value & Access IT Director
Liaise with broad team including Market Access Operations, US Commercial Legal, Internal Audit, IT Vendor Management, IT Risk & Controls, and Finance
Infuse forward-thinking and innovative approaches to building and implementing technologies supporting business scaling
Serve as go-to person for Value & Access IT operational needs, including onboarding new team members, overseeing managed services providers, and owning IT processes for day-to-day operations
Involved from inception of IT solution ideas through successful execution, including enhancements to Revenue Management tools (Model N system modules), system security assessments of third-party SaaS solutions, and implementation of new technologies
Demonstrate clear understanding of business objectives and ability to identify measurable value for proposed and implemented technologies
Provide new technology project support and oversee day-to-day operations of US-based Value & Access systems
Advise management on business opportunities enabled through technologies
Ensure activities, budgets, and portfolios are strategically and operationally aligned with business needs and IT strategies
Proactively identify and promote technological solutions to existing or emerging business issues
Work with leadership teams across functions to position technology as a competitive advantage
Ensure projects are managed and monitored to meet benefits, identifying and solving bottlenecks/failures timely
Actively explore opportunities to enhance customer-facing processes through technology recommendations
Understand processes, plans, objectives, drivers, issues facing business teams, and underlying external policies/regulations
Ensure availability of appropriate project plans for system implementations addressing technical, process, training, and support perspectives

Responsibilities

Advise IT and business leadership on capability enablement opportunities through Revenue Management technology portfolio
Ensure activities, budgets, and system portfolios are strategically aligned with business needs and IT strategies
Turn business strategy into clearly defined, beneficial, and cost-effective IT projects ready for implementation

Skills

IT Business Analysis

Vendor Management

IT Risk & Controls

Market Access Operations

Technical Leadership

Process Ownership

Managed Services

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free